Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

NCT06795451 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT06795451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
Lead sponsor
University of Cincinnati
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 25, 2025
Completion date
March 31, 2027
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder